Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

270 results about "Brain gliomas" patented technology

Glioma is a broad category of brain and spinal cord tumors that come from glial cells brain cells that support nerve cells.

Microbial marker for predicting risk of brain glioma and application thereof

The present disclosure provides a microbial marker for predicting the risk of brain glioma, and a computational model based on the microbial marker. The microbial marker fills the blank of brain glioma risk assessment by using a saliva flora microbiome model, and the developed risk scoring model provides a new tool for the risk assessment of the brain glioma. The model is based on the analysis of saliva microbiome, reveals the potential relation between specific microorganisms and brain glioma risk, and provides support for the prevention and management of brain glioma.
Owner:CANCER INST & HOSPITAL CHINESE ACADEMY OF MEDICAL SCI

Brain glioma segmentation method and system based on region of interest in combination with artificial intelligence

The invention provides a brain glioma segmentation method and system based on a region of interest combined with artificial intelligence, and relates to the technical field of image segmentation, and the method comprises the steps: carrying out the preprocessing of a brain magnetic resonance image; extracting image features by using a multi-scale convolutional neural network; calculating an attention weight to generate a thermodynamic diagram, and binarizing to obtain a candidate region; adaptively adjusting convolution kernel parameters according to the size of the candidate region, extracting multi-scale features by adopting spatial pyramid pooling, and fusing the multi-scale features; semantic segmentation is carried out through a segmentation module; and marking a brain glioma area. According to the method, the accuracy and efficiency of brain glioma segmentation are improved, and the consumption of computing resources is reduced.
Owner:THE AFFILIATED HOSPITAL OF SHANDONG UNIV OF TCM

Brain colloid nodule region segmentation method and electronic equipment

The invention provides a brain colloid nodule region segmentation method and electronic equipment, which can be applied to the technical fields of artificial intelligence and medical image processing. The method comprises the following steps: preprocessing original nuclear magnetic image data of a brain area to obtain preprocessed nuclear magnetic image data; inputting nuclear magnetic image data into encoder branches of the segmentation model, and outputting encoding features of multiple scales; inputting the coding features of the plurality of scales into a decoder branch of a segmentation model, determining respective segmentation results of the plurality of scales, and outputting a region segmentation result for the nuclear magnetic image data according to the respective segmentation results of the plurality of scales; wherein the region segmentation result comprises a plurality of channels, and the region segmentation result of each channel represents the distribution of a sub-region of the brain glioma.
Owner:TIANJIN UNIV

Brain glioma full-section pathological image intelligent analysis method based on double-path analysis framework

A brain glioma full-slice pathological image intelligent analysis method based on a double-path analysis framework specifically comprises the following steps: S1, preprocessing full-slice images, dividing each full-slice image into different foreground tissue areas and background areas by using a channel threshold segmentation algorithm, and performing image segmentation on the foreground tissue areas and the background areas; cutting the foreground tissue region into a plurality of image blocks with fixed sizes, and extracting a feature vector of each image block to form a feature cluster; s2, establishing a dynamic sampling mechanism, performing dynamic multi-instance learning on the feature cluster of each full-slice image by using a two-stage attention network, and finally obtaining slice-level feature representation of the full-slice image; and S3, quantifying tumor microenvironment spatial relationship information to obtain a feature representation of a spatial relationship quantization graph, and splicing the feature representation with the slice-level feature representation in the S2 to obtain a final prediction result. According to the method, the prediction efficiency and robustness are improved, and the medical decision speed and quality are improved.
Owner:FUDAN UNIVERSITY

Brain glioma heterogeneity pathology visualization method and device based on multi-modal image

The invention relates to the field of medical image processing and pathological diagnosis, aims to solve the problems that brain glioma multi-modal image fusion precision is low, heterogeneity feature and pathological association is weak, and visualization readability is poor, and provides a visualization method and device. The method comprises the steps of multi-modal image preprocessing and registration, regional adaptive multi-modal fusion, pathology association type heterogeneity feature quantification, multi-dimensional pathology visualization, and result verification and optimization. Images are rigidly registered and aligned through mutual information, features are enhanced by adopting a regional differentiation attention fusion algorithm, features are quantified through an improved LSSVM, pathological gold standards are associated, and a three-dimensional visualization model is constructed to visually present heterogeneity information. The device comprises a memory and a processor and can execute the method. According to the method, the heterogeneity evaluation accuracy and clinical readability are improved, treatment scheme optimization is assisted, and the method is suitable for accurate diagnosis and treatment scenes of brain glioma.
Owner:WENZHOU MEDICAL UNIV

Multi-mode nuclear magnetic resonance image glioma segmentation method and application thereof

The invention provides a multi-mode nuclear magnetic resonance image glioma segmentation method and application thereof, and belongs to the field of medical image processing. The invention provides an M2ES-UNet network aiming at the problems of insufficient utilization of spatial features, single multi-modal fusion mechanism and cross-level semantic loss of an existing segmentation method. According to the method, multi-view anatomical information is extracted through a multi-plane feature collaboration module; utilizing an orthogonal dimension fusion convolution and modal introspection-collaboration module to respectively realize differential fusion of shallow and deep features; and the progressive jump transmission of the features is realized through a coding information smooth transmission module. According to the method, multi-plane and multi-mode complementary information can be effectively mined, the boundary precision and robustness of brain glioma segmentation are remarkably improved, and clinical diagnosis is assisted.
Owner:CHINA JILIANG UNIV

Osthole compound, metal complex and preparation method and application thereof

The invention discloses an osthole compound, a metal complex and a preparation method and application of the osthole compound, the osthole compound (OST-Alkyne) has remarkable anti-tumor biological activity, osthole (OST) and a cyclometalated iridium precursor are further connected through a copper-catalyzed azide-alkyne cycloaddition (CuAAC) reaction, higher anti-tumor activity is shown, and the osthole compound has a good application prospect. Mitochondria is targeted, and tumor is killed by reducing mitochondrial membrane potential and inducing cell autophagy and necrotic apoptosis; according to the invention, natural products are combined with metals, so that not only are good selectivity and anti-proliferation ability to brain glioma cells realized, but also toxic and side effects to normal cells are overcome, a new design idea is provided for novel metal drugs to treat brain glioma, and the application prospect is wide.
Owner:NANJING NORMAL UNIVERSITY

Application of combination of fludarabine and temozolomide in treatment of brain glioma

The invention relates to an application of a combination of fludarabine and temozolomide in treatment of brain glioma. A drug combination composition comprises fludarabine and temozolomide. The temozolomide and the fludarabine are combined for use, so that a synergistic interaction effect is generated on treatment of the brain glioma, and the effect is obviously better than that of single use of the temozolomide and the fludarabine. Therefore, the pharmaceutical composition for treating the brain glioma, provided by the invention, can be used for remarkably inhibiting the growth of the brain glioma cells and prolonging the lifetime of a patient, and a brand new strategy and thought are provided for the treatment of the brain glioma.
Owner:INSTITUTE OF BASIC MEDICAL SCIENCES CHINESE ACADEMY OF MEDICAL SCIENCES

Curcumin delivery system based on small extracellular vesicles, preparation method and application

The invention particularly relates to a curcumin delivery system based on small extracellular vesicles, a preparation method and application. Curcumin has the defects of poor water solubility, poor chemical stability and insufficient targeting, in order to improve the bioavailability of curcumin, the curcumin delivery system based on small extracellular vesicles provided by the invention adopts RGD peptide surface modified sEVs as a carrier to coat curcumin, and saponin is used for assisting ultrasonic drug loading, so that the drug loading rate of curcumin is improved. According to verification of the invention, the delivery system can effectively improve the in-vitro release performance of the curcumin preparation and realize controlled release and slow release. Meanwhile, the delivery system effectively improves apoptosis induction of curcumin to glioma cells, the blood-brain barrier penetrating capacity of the curcumin delivery system is improved, and the treatment effect on brain glioma is expected to be improved.
Owner:LIAOCHENG PEOPLES HOSPITAL

Method for establishing brain glioma hierarchical hybrid network based on multi-view feature fusion

The invention discloses a method for establishing a brain glioma hierarchical hybrid network based on multi-view feature fusion. The method comprises four steps of data preprocessing, feature extraction, multi-view feature fusion and hierarchical processing of obtained features through a classifier. The global receptive field and the inductive bias can be balanced, the global and local multi-scale and multi-granularity features are combined, the global receptive field and the inductive bias are balanced, and the feature extraction capability is enhanced; by constructing different view angle data sources (an interlayer view angle, a scanning plane view angle and a modal view angle) and designing a novel feature fusion module, a network can fully and effectively utilize key information, including interlayer, space and multi-modal information, provided by MRI (Magnetic Resonance Imaging) of different scanning planes and different modals, so that comprehensive cognition of brain glioma is realized.
Owner:ZHENGZHOU UNIV

Drug carrier as well as preparation method and application thereof

The invention belongs to the technical field of biochemistry, and particularly relates to a drug carrier and a preparation method and application thereof, and the preparation method comprises the following steps: fully dissolving an amphiphilic prodrug compound in methanol to obtain a prodrug solution; carrying out nitrogen film blowing on the prodrug solution by using a nitrogen blowing instrument to form a layer of uniform film on the wall of the container, and carrying out vacuum drying overnight for later use; and removing the residual organic solvent from the film, adding ultrapure water, and carrying out water bath and ultrasonic treatment to obtain the drug carrier. The amphiphilic nano-carrier is constructed through a film ultrasonic dispersion method, the solubility of the drug is increased, the in-vivo pharmacokinetic characteristics are improved, a contrast agent, a photosensitizer and the like can be loaded, combined therapy such as chemotherapy / photodynamic therapy and the like can be achieved while diagnosis of brain glioma is achieved, tumor growth is inhibited to the maximum extent, and the application prospect is wide. The design and preparation of the nano-carrier can provide a new thought and a new method for clinical diagnosis and treatment of brain glioma.
Owner:DALIAN NATIONALITIES UNIVERSITY

CSF1R prediction method in brain glioma, storage medium and device

The invention relates to a CSF1R prediction method in brain glioma, a storage medium and a device, and belongs to the technical field of medical information analysis. The method comprises the following steps: preprocessing magnetic resonance image data; extracting a radiomics feature CR of the magnetic resonance image data; performing multi-angle and multi-slice 2D image analysis and processing on the magnetic resonance image data, inputting the processed data into a convolutional neural network for training, and extracting a deep learning feature DL of the last convolutional layer; fusing the radiomics feature CR and the deep learning feature DL to obtain a feature S; and inputting the feature S into a pre-trained machine learning ensemble learning strategy, performing CSF1R label prediction, and finally obtaining a CSF1R prediction result. According to the method, the end-to-end automatic process is realized, the advantages of multi-modal data, radiomics and deep learning are combined, the prediction accuracy and efficiency are remarkably improved, and powerful support is provided for diagnosis and treatment of brain glioma.
Owner:AFFILIATED HUSN HOSPITAL OF FUDAN UNIV

Brain glioma microenvironment formation key molecular mechanism analysis method

The invention relates to the technical field of biological information, in particular to a brain glioma microenvironment formation key molecular mechanism analysis method, which comprises the following steps: calling expression data to analyze a cell marker sequence to construct a segmentation interval, calculating a candidate factor expression direction to judge trend consistency, identifying expression aggregation difference to construct a split node section, and constructing a subsection; according to the method, partitions are constructed on the basis of marker expression syn-position, judgment is carried out in combination with candidate factor expression directions and marker trends, factor collaboration features are constructed according to the number of trends consistent times, and the semantic sorting information is generated by analyzing the channel change trends to generate drift scores, evaluating multi-label output stability screening key factors and analyzing literature word order positions. Identifying and expressing an aggregation and split structure, guiding a functional pathway to perform trend analysis in a scoring interval and construct a dynamic trajectory, judging label stability and empowerment according to pathway scoring difference, and determining a factor semantic position in combination with a literature word order structure to realize integrated support of regulation and control information and literature evidence.
Owner:THE FIRST AFFILIATED HOSPITAL OF ARMY MEDICAL UNIV

Planning method, device and equipment for treating brain glioma through multi-fiber laser ablation

The invention relates to a planning method, device and equipment for treating brain glioma through multi-fiber laser ablation. The method comprises the following steps: according to pre-acquired image information of a target patient and a segmentation result of a tumor region, sequentially performing segmentation sampling processing on the image information to obtain a candidate optical fiber path set; screening the candidate optical fiber path set according to an optical fiber planning objective function and an optical fiber planning constraint condition to obtain an intermediate optical fiber path set, and determining the number of optical fibers required by tumor ablation according to the intermediate optical fiber path set; determining a target optical fiber path set from the intermediate optical fiber path set according to the number of optical fibers required by tumor ablation and a predetermined path evaluation score; the target optical fiber path set at least comprises position information corresponding to each target optical fiber path. The method can improve the tumor ablation rate and reduce the use of optical fibers.
Owner:TSINGHUA UNIVERSITY

Brain glioma intestinal microbial marker, product and application thereof

The invention discloses a brain glioma intestinal microbial marker, a product and application of the brain glioma intestinal microbial marker, and belongs to the field of biological medicine. The invention relates to an enteric microbial marker, which is characterized by being prepared from one or more of Eubacter algenti, Prevotella copri, Alistipes finegili, Bifidobacterium adolescentis and Citrobacter sp., and the enteric microbial marker is prepared from one or more of Eubacter algenti, Prevotella copri, Alistipes finegili, Bifidobacterium adolescentis and Citrobacter sp., and the enteric microbial marker is prepared from one or more of Eubacter algenti, Prevotella copri, Alistipes finegili, Bifidobacterium adolescentis and Citrobacter sp. The invention provides a kit which comprises a detection reagent for detecting the relative abundance of the intestinal microbial marker. The invention provides a product for diagnosing brain glioma and a computer program product related to the brain glioma. The product provided by the invention has good feasibility and accuracy, and provides a new tool for clinical diagnosis.
Owner:ZHONGNAN HOSPITAL OF WUHAN UNIV +1

Nanometer vesicle for targeted brain glioma metabolic immune remodeling as well as preparation method and application of nanometer vesicle

The invention relates to the technical field of biological medicine, in particular to a nano-vesicle for targeted brain glioma metabolic immune remodeling and a preparation method and application thereof. According to the nano-vesicle for targeted brain glioma metabolism immune remodeling, double-target metabolism and cascade responsive cleavage site modified biological vesicles are integrated, and effective penetration of a drug blood brain barrier and precise targeting of brain glioma can be achieved. The ROS responsive nanoparticles II are prepared by selecting BSA as a drug carrier, applying a nanoprecipitation method and utilizing SLC1A5, LDHA antagonists and responsive linkers, so that the metabolic double-target inhibitor only responds to specific ROS of tumor cells, and specific release in the tumor cells is realized. The cascade response polypeptide provides a simple and convenient delivery scheme with low invasiveness and application prospects for treatment of brain glioma, and is expected to realize precise and individualized treatment in the field of treatment of malignant glioma.
Owner:INST OF BIOMEDICAL ENG CHINESE ACAD OF MEDICAL SCI

Brain glioma CT-MRI multi-modal fusion intelligent grading method and system

The invention provides a brain glioma CT-MRI (Computed Tomography-Magnetic Resonance Imaging) multi-modal fusion intelligent grading method and a brain glioma CT-MRI multi-modal fusion intelligent grading system, and relates to the field of medical image processing and intelligent diagnosis, and the method comprises the following steps: obtaining CT image and MRI image data of a brain glioma patient through a medical image acquisition device, carrying out standardized preprocessing on the CT image and the MRI image data, and generating a preprocessed image data set; and spatial alignment is carried out on the preprocessed image data set, CT-MRI registration image data are output, and a multi-scale registration method is adopted for spatial alignment. According to the CT-MRI multi-modal fusion intelligent grading method and system based on the brain glioma, by providing the CT-MRI multi-modal fusion intelligent grading method, the problem that in the prior art, image registration and feature fusion are not accurate is solved. A multi-scale registration method and a weighted combined feature extraction mode are adopted, accurate registration of CT and MRI images and efficient fusion of features are ensured, and therefore the accuracy and stability of a grading model are improved.
Owner:ANHUI MAGNETIC SPIN TECH CO LTD

Brain glioma image segmentation method based on deep learning

The invention discloses a brain glioma image segmentation method based on deep learning, and relates to the technical field of image processing. Comprising the following steps: acquiring a multi-modal MRI image and preprocessing the multi-modal MRI image to obtain a multi-channel input image tensor; inputting the multi-channel input image tensor into a feature extraction module to obtain a first loss; establishing an improved UNet model, training the improved UNet model by using a multi-channel input image tensor to obtain a second loss, and adjusting parameters of the improved UNet model in combination with the first loss and the second loss to obtain a trained model; the improved UNet model is based on the UNet model, an improved hypergraph convolution module is introduced into the deepest layer of the UNet model, a multi-scale dynamic weighted feature pyramid module is introduced in a jump connection stage, and a double attention mechanism is introduced in a feature recovery stage; and taking a to-be-segmented brain glioma image, and segmenting the to-be-segmented brain glioma image by using the trained model. According to the method provided by the invention, the segmentation precision and accuracy are greatly improved.
Owner:SOUTHWEST PETROLEUM UNIV

Brain glioma segmentation method based on CrossMAE

The invention discloses a brain glioma segmentation method based on CrossMAE, and aims to enhance segmentation performance by extracting visual language representation through combination of MRI and a diagnostic report. According to the method, image and text information is randomly masked, masked content is reconstructed, and cross-modal deep association is learned, so that accurate segmentation of MRI brain glioma is realized. The method comprises the following steps: S1, collecting a multi-modal MR brain tumor image and a diagnosis report, and constructing a data set; s2, designing an image-text joint mask strategy, and performing selective masking processing on the data; s3, constructing an MRI (Magnetic Resonance Imaging) brain glioma segmentation model based on the CrossMAE; s4, designing a multi-task cascade loss function, and training and optimizing the segmentation model by using the data set to obtain a trained MRI brain glioma segmentation model; and S5, performing MRI brain glioma segmentation according to the trained MRI brain glioma segmentation model. According to the method, the cross-modal complementary information is effectively extracted and utilized from the MRI, so that accurate segmentation of the MRI brain glioma is realized.
Owner:GUANGZHOU YIZHI INTELLECTUAL PROPERTY OPERATION CO LTD

Application of combination of 3-indoleacetic acid and temozolomide in resisting brain glioma

The invention provides application of 3-indoleacetic acid combined with temozolomide in resisting brain glioma, and belongs to the field of biological medicine. Wherein the 3-indoleacetic acid can significantly enhance the inhibition effect of temozolomide on brain glioma cells in a short period and a long period, and can significantly enhance the apoptosis induction effect of temozolomide on the brain glioma cells, and after the 3-indoleacetic acid and temozolomide are applied to a brain glioma animal model, the 3-indoleacetic acid and temozolomide are combined, so that the inhibition effect of temozolomide on brain glioma cells is obviously improved. The 3-indoleacetic acid and temozolomide can obviously inhibit the development of brain glioma and relieve weight loss caused by temozolomide administration, so that the 3-indoleacetic acid and temozolomide have the potential of being developed into the anti-brain glioma medicine.
Owner:JIANGHAN UNIVERSITY

Brain glioma organ chip with adjustable tumor microenvironment gradient and method for mediating formation of brain glioma organoid by brain glioma organ chip

The invention discloses a brain glioma organ chip with adjustable tumor microenvironment gradient and a method for mediating formation of brain glioma organoid by the brain glioma organ chip, and belongs to the technical field of organ chips. The preparation method comprises the following steps: firstly, preparing a glioma organ chip with adjustable tumor microenvironment gradient by utilizing a prepolymer solution containing glioma cells and vascular endothelial cells and a prepolymer solution containing biochemical molecules; then, the obtained brain glioma organ chip with the adjustable tumor microenvironment gradient is subjected to three-dimensional dynamic co-culture under the perfusion condition, three-dimensional culture and co-culture of brain glioma cells and vascular endothelial cells are achieved at the same time, endothelial-glioma multicellular tumor spheres are formed, and construction of brain glioma organs is achieved. The brain glioma organoid established by the invention successfully summarizes key characteristics of a tumor microenvironment, including biophysical factors simulated by physiological fluid and biochemical factors of three-dimensional culture microgel with adjustable concentration gradient of biochemical molecules.
Owner:SHANGHAI UNIV

Brain glioma grading method based on multi-instance causal characterization learning

The invention relates to a brain glioma grading method based on multi-instance causal characterization learning, and the method comprises the following steps: S1, data preprocessing, S2, feature extraction through ResNet-50, S3, feature coding of high-dimensional feature representations of instances, S4, decoupling of low-dimensional feature representations of each instance, obtaining causal features and non-causal features, and carrying out classification on the causal features and the non-causal features. S5, constructing an adaptive adjacency matrix A, constructing a sparse adjacency matrix A (k) by adopting a Topk neighbor selection strategy, and carrying out information aggregation through a graph neural network to obtain aggregation features; S6, carrying out local feature aggregation on each scanning plane p, calculating a weight weighted p of each scanning plane by utilizing a full-connection network, and carrying out weighted fusion to obtain an aggregation feature; s7, fusing and grading the aggregated features and the features; the method has the advantage of improving the stability and clinical applicability of the grading model.
Owner:THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIV

Brain glioma classification method and device based on multi-modal MRI

The invention discloses a brain glioma classification method and device based on multi-mode MRI, and relates to the technical field of image processing. According to the method, multiple tumor sub-regions of the brain glioma are acquired based on a to-be-processed multi-modal MR image, multiple local ROIs are extracted based on the multiple tumor sub-regions, and then the sub-type of the brain glioma is determined based on the multiple local ROIs and a global ROI. The subtype can be determined through the multi-modal MR image, so that on one hand, non-invasive identification of the subtype is realized, and bleeding and infection risks caused by identification of the subtype are avoided; and on the other hand, the classification accuracy can be improved by utilizing complementary information between different modal images and a boundary form between different tumor sub-regions. Besides, through the fine structure features of each tumor sub-region reserved from a plurality of visual angles by the plurality of local ROIs, and in combination with the spatial distribution context information of the whole brain glioma provided by the global ROI, a better balance between the processing precision and the calculation efficiency can be realized.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV +1

Application of compound Merulin A in preparation of anti-glioma drug

The invention belongs to the technical field of biological medicines, and particularly relates to application of a compound Merulin A in preparation of anti-glioma medicines. The invention provides an application of a compound Merulin A in preparation of a drug for resisting brain glioma. Experiments prove that the compound Merulin A shows remarkable anti-glioma activity, can effectively promote early apoptosis and necrosis of glioma cells, and further inhibits proliferation and migration of the glioma cells. Moreover, due to the advantages of being wide in source, simple in extraction process, short in period, low in cost and the like, the compound Merulin A has a wide application prospect as the anti-glioma drug.
Owner:SUN YAT SEN UNIV

Brain glioma diagnosis system based on platelet alpha particle super-resolution imaging

The invention discloses a brain glioma diagnosis system based on platelet alpha particle super-resolution imaging. The brain glioma diagnosis system comprises a platelet alpha particle super-resolution image acquisition module, an image analysis module and a brain glioma diagnosis module, wherein the image analysis module is used for accounting an average alpha particle area value in each platelet in an obtained alpha particle super-resolution image, and the brain glioma diagnosis module judges that the greater the average alpha particle area value in each platelet is, the greater the possibility of suffering from the brain glioma is, and the greater the possibility of suffering from the brain glioma is. Especially, diagnosis is carried out by taking an average alpha particle area value in each platelet and a platelet proportion of alpha particles' Nlt; 30 'as combined indexes, the diagnosis accuracy of the system can reach 90%, the sensitivity is 86.70%, and the specificity is 80.00%. The brain glioma diagnosis system provided by the invention is small in required detection invasiveness, high in sensitivity, good in specificity and capable of quickly and accurately identifying a brain glioma patient.
Owner:HUAZHONG UNIV OF SCI & TECH +2

Bionic nano-drug delivery system for targeted regulation of immune function of microglial cells

PendingCN119455005AImprove brain efficiencyImprove the effect of immunotherapyOrganic active ingredientsPharmaceutical non-active ingredientsImmune checkpointMacrophage cell
The invention belongs to the technical field of pharmaceutical preparations, and relates to a bionic nano-drug delivery system for targeted regulation of microglial cell immune function, in particular to a bionic nano-drug delivery system for targeted regulation of microglial cell immune function and having the effect of an immune checkpoint inhibitor and application of the bionic nano-drug delivery system in brain glioma immunotherapy. The drug delivery system is a bionic nano drug delivery system prepared from an oleanolic acid nanocrystal core (OA-core), an M0 or M2 type macrophage membrane and an acid-sensitive lipid material connected with immune checkpoint antagonistic polypeptide. The bionic nano-drug delivery system constructed by the invention can realize co-loading of small molecule drugs and polypeptide drugs and precise delivery and graded release of focus parts, regulates and controls the brain glioma immune process in a multi-target manner, synergistically enhances the anti-glioma immune effect, and has a wide application prospect.
Owner:FUDAN UNIVERSITY

Application of Semaphorin 3G overexpression adeno-associated virus vector in preparation of brain glioma treatment medicine

The invention belongs to the field of tumor drugs, and particularly relates to application of an adeno-associated virus vector overexpressing Semaphorin 3G in preparation of drugs for treating brain glioma. The AAV-SEMA3G can effectively reduce the growth speed of brain glioma of mice and prolong the survival time of tumor-bearing mice, and can be particularly used for preparing drugs for treating brain glioma and the like. The invention discloses an application of AAV-SEMA3G in preparation of a medicine for treating brain glioma.
Owner:NANJING MEDICAL UNIV

A nanomaterial, a preparation method and application thereof

The application discloses a kind of nanomaterial and its preparation method and application, the nanomaterial includes exosome and liposome;The exosome expresses immune checkpoint, the exosome is derived from brain glioma cell;The liposome is loaded with I type photosensitizer.The application is by PDT, immune checkpoint and brain glioma cell exosome antigen three tubes simultaneously to remodel tumor local immune microenvironment, greatly improve the efficiency of cancer immunotherapy, can activate strong anti brain glioma immune response and overcome immune escape.
Owner:SUN YAT SEN UNIV

Method for constructing brain glioma organoid with reserved immune microenvironment

The invention provides a method for constructing a brain glioma organ retaining an immune microenvironment, and the culture medium, the culture system and the method provided by the invention overcome the shortages that a large number of tumor immune cells are lost and the tumor immune microenvironment is greatly damaged along with the prolonging of culture time of a current glioma organ model. The tumor microenvironment of the glioblastoma can be more completely reserved for a longer time, the heterogeneity of organoid tissues is greatly reserved, and the model is suitable for being used as a new generation of glioblastoma organoid models; a more reliable research tool is provided for the tumor microenvironment research, the tumor generation mechanism research, the drug effect screening, the development and application of a disease model and the like of the glioblastoma.
Owner:BEIJING NEUROSURGICAL INST +1

Fe-based T7 peptide targeted glioma micromolecular magnetic resonance contrast agent and preparation and synthesis method and application thereof

The invention discloses a Fe-based T7 peptide targeted glioma micromolecular magnetic resonance contrast agent and a synthesis method and application thereof.The micromolecular magnetic resonance contrast agent is characterized in that one part of the micromolecular magnetic resonance contrast agent is targeted peptide, the other part of the micromolecular magnetic resonance contrast agent is an iron-coordinated pyridine ring contrast agent, and the targeted peptide and the iron-coordinated pyridine ring contrast agent are connected through click reaction. The T7 peptide part in the micromolecule magnetic resonance contrast agent can be combined with a transferrin receptor and can be more efficiently conveyed to the brain for imaging. Compared with a traditional Gd-based contrast agent, the magnetic resonance contrast agent disclosed by the invention has higher specificity and lower toxicity, and meanwhile, the contrast agent has better stability and can be used for efficiently imaging in-situ brain glioma.
Owner:INNOVATION ACAD FOR PRECISION MEASUREMENT SCI & TECH CAS